EPSTATE SR 150

Description

Epalrestat 150 mg EPSTATE SR 150 is a sustained-release medication formulated with Epalrestat 150 mg, primarily used to manage diabetic peripheral neuropathy. It helps protect nerve function and improve symptoms associated with nerve damage caused by diabetes. Key Ingredients: Epalrestat 150 mg: The active component that belongs to the class of aldose reductase inhibitors, targeting nerve damage related to diabetes. Key Benefits: Helps alleviate symptoms of diabetic nerve pain, such as numbness, tingling, and burning sensations. Protects nerve fibers from further damage by inhibiting aldose reductase, an enzyme involved in diabetic complications. Supports improved nerve function and enhances quality of life for diabetic patients. Sustained-release formulation ensures a gradual and consistent effect throughout the day. How Does It Work? Epalrestat works by inhibiting aldose reductase, an enzyme that plays a key role in the development of diabetic neuropathy. By reducing the activity of this enzyme, Epalrestat prevents the accumulation of sorbitol in nerve cells, which is a major factor in nerve damage. This action helps in relieving neuropathic symptoms and protecting nerves from further injury. Directions for Use: Take EPSTATE SR 150 exactly as prescribed by your healthcare provider. Usually administered once daily, with or without food. Swallow the capsule whole; do not crush or chew. Consistency is essential for optimal results; follow the recommended duration of therapy. Do not exceed the prescribed dose without consulting your doctor. Side Effects: While generally well-tolerated, some individuals may experience side effects such as: Mild gastrointestinal discomfort (nausea, stomach upset) Headache Dizziness Allergic reactions (rash, itching, swelling) in rare cases Any unusual symptoms should be reported to your healthcare provider promptly.